🔎 Trials Near Me

首頁 › 急性髓系白血病 › 愛達荷

愛達荷 的 急性髓系白血病 臨床試驗

9 項針對 急性髓系白血病 的研究正在 愛達荷 各地點尋找參與者。

愛達荷 的城市

官方研究文本（英文）

Comparing Different Treatment Lengths for Venetoclax in Older People With Newly Diagnosed Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)

  • Kootenai Health - Coeur d'Alene, Coeur d'Alene
  • Kootenai Clinic Cancer Services - Post Falls, Post Falls
  • Kootenai Clinic Cancer Services - Sandpoint, Sandpoint
招募中2 期
60 歲及以上 · 所有性別 · 更新於 2026年10月5日 · NCT07437950

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

  • Saint Alphonsus Cancer Care Center-Boise, Boise
  • Saint Luke's Cancer Institute - Boise, Boise
  • Saint Alphonsus Cancer Care Center-Caldwell, Caldwell
  • 還有 7 項
招募中2 期
18 歲及以上 · 所有性別 · 更新於 2026年10月5日 · NCT05564390

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • Saint Alphonsus Cancer Care Center-Boise, Boise
  • Saint Luke's Cancer Institute - Boise, Boise
  • Saint Alphonsus Cancer Care Center-Caldwell, Caldwell
  • 還有 9 項
招募中觀察性研究歡迎健康志工
40 至 75 歲 · 所有性別 · 更新於 2026年10月2日 · NCT05334069

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

  • Saint Alphonsus Cancer Care Center-Boise, Boise
  • Saint Luke's Cancer Institute - Boise, Boise
  • Saint Alphonsus Cancer Care Center-Caldwell, Caldwell
  • 還有 7 項
招募中2 期
18 至 59 歲 · 所有性別 · 更新於 2026年9月28日 · NCT05554393

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

  • Saint Luke's Cancer Institute - Boise, Boise
  • Kootenai Health - Coeur d'Alene, Coeur d'Alene
  • Saint Luke's Cancer Institute - Fruitland, Fruitland
  • 還有 5 項
招募中2 期
18 歲及以上 · 所有性別 · 更新於 2026年9月22日 · NCT06672146

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

  • Saint Alphonsus Cancer Care Center-Boise, Boise
  • Saint Luke's Cancer Institute - Boise, Boise
  • Saint Alphonsus Cancer Care Center-Caldwell, Caldwell
  • 還有 7 項
招募中2 期
18 至 59 歲 · 所有性別 · 更新於 2026年9月22日 · NCT05554406

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

  • Saint Alphonsus Cancer Care Center-Boise, Boise
  • Saint Luke's Cancer Institute - Boise, Boise
  • Saint Alphonsus Cancer Care Center-Caldwell, Caldwell
  • 還有 7 項
招募中2 期
18 歲及以上 · 所有性別 · 更新於 2026年9月22日 · NCT06317649

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

  • Saint Luke's Cancer Institute - Boise, Boise
招募中3 期
6 Months – 21 Years · 所有性別 · 更新於 2026年9月17日 · NCT04293562

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

  • Saint Luke's Cancer Institute - Boise, Boise
招募中1/2 期
22 歲以下 · 所有性別 · 更新於 2026年8月25日 · NCT04726241

資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。